Neal Lakdawala, MD

neal lakdawala
Director, Cardiovascular Genetics Clinic
Brigham and Women’s Hospital, Harvard Medical School

Dr. Neal Lakdawala conducts natural history studies, translational research and clinical trials in patients with genetic cardiomyopathies.  He directs the cardiovascular genetics clinic at Brigham and Women’s Hospital and is the director of the dilated and arrhythmogenic cohort in the international, multicenter, SHaRe study. 

 

 

 

 

 

 

 

 

 

Publications

  1. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Heymans S et al. (2023). Lancet
  1. Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy. Tremblay-Gravel M. et al. (2023). Circulation Genomics and Precision Medicine
  1. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.  Lakdawala, NK. et al. (2021) Circulation Genomics and Precision Medicine
  1. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Olivotto I. et al. (2020).  Lancet 
  1. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. Eberly LA. et al. (2020). The Journal of the American Medical Association